These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32500748)

  • 1. Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes: real-world data from the FANTASIIA Registry.
    García-Fernández A; Esteve-Pastor MA; Roldán-Rabadán I; Muñiz J; Ruiz Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Otero D; Anguita M; Lip GYH; Marín F;
    Ann Med; 2020 Sep; 52(6):300-309. PubMed ID: 32500748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of oral anticoagulation with vitamin K antagonists in 'real-world' patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry.
    Esteve-Pastor MA; Rivera-Caravaca JM; Roldán-Rabadán I; Roldán V; Muñiz J; Raña-Míguez P; Ruiz-Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Anguita M; Lip GYH; Marín F;
    Europace; 2018 Sep; 20(9):1435-1441. PubMed ID: 29095971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry.
    Bertomeu-Gonzalez V; Moreno-Arribas J; Esteve-Pastor MA; Roldán-Rabadán I; Muñiz J; Raña-Míguez P; Ruiz-Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Anguita M; Lip GYH; Marín F;
    J Am Heart Assoc; 2020 Jan; 9(1):e013789. PubMed ID: 31870235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry.
    Esteve-Pastor MA; Rivera-Caravaca JM; Roldán-Rabadán I; Roldán V; Muñiz J; Raña-Míguez P; Ruiz-Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Anguita M; Lip GYH; Marín F;
    Thromb Haemost; 2018 Feb; 118(2):279-287. PubMed ID: 29443369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report.
    Fumagalli S; Said SA; Laroche C; Gabbai D; Boni S; Marchionni N; Boriani G; Maggioni AP; Musialik-Lydka A; Sokal A; Petersen J; Crijns HJGM; Lip GYH;
    Eur Heart J Cardiovasc Pharmacother; 2018 Jul; 4(3):172-179. PubMed ID: 29309557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between body mass index and mortality in atrial fibrillation patients with and without diabetes mellitus: Insights from a multicenter registry study in China.
    Lyu SQ; Yang YM; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Ren JM
    Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2242-2251. PubMed ID: 32900569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a "Real-world" Nationwide Registry: Insights From the FANTASIIA Study.
    Ortiz MR; Muñiz J; Esteve-Pastor MA; Marín F; Roldán I; Cequier A; Martínez-Sellés M; Saldivar HG; Bertomeu V; Anguita M
    J Cardiovasc Pharmacol Ther; 2020 Jul; 25(4):316-323. PubMed ID: 32228180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance of atrial fibrillation treatment with the ABC pathway in patients with concomitant diabetes mellitus in the Middle East based on the Gulf SAFE registry.
    Domek M; Gumprecht J; Li YG; Proietti M; Rashed W; Al Qudaimi A; Gumprecht J; Zubaid M; Lip GYH
    Eur J Clin Invest; 2021 Mar; 51(3):e13385. PubMed ID: 32810282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registry.
    Bertomeu-Gonzalez V; Moreno-Arribas J; Esteve-Pastor MA; Roldán-Rabadán I; Muñiz J; Otero García D; Ruiz-Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Anguita M; Lip GYH; Marín F;
    Eur J Clin Invest; 2021 Apr; 51(4):e13431. PubMed ID: 33065765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of quality of anticoagulation control with different management systems among patients with atrial fibrillation: Data from FANTASIIA Registry.
    Roldán Rabadán I; Esteve-Pastor MA; Anguita-Sánchez M; Muñiz J; Camacho Siles J; Quesada MA; Ruiz Ortiz M; Marín F; Martínez Sellés M; Bertomeu V; Lip GYH; Cequier Fillat A; Badimón L;
    Eur J Clin Invest; 2018 May; 48(5):e12910. PubMed ID: 29424018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of sex on long-term prognosis in patients with atrial fibrillation treated with oral anticoagulants. Results from the prospective, nationwide FANTASIIA study.
    Roldán Rabadán I; Esteve-Pastor MA; Anguita Sánchez M; Muñiz J; Ruiz Ortiz M; Marín F; Roldán V; Quesada MA; Camacho Siles J; Cequier Fillat A; Bertomeu Martinez V; Martínez Sellés M; Badimón L;
    Eur J Intern Med; 2020 Aug; 78():63-68. PubMed ID: 32303456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation.
    Pastori D; Pignatelli P; Saliola M; Carnevale R; Vicario T; Del Ben M; Cangemi R; Barillà F; Lip GY; Violi F
    Int J Cardiol; 2015 Dec; 201():513-6. PubMed ID: 26318513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
    O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Integrated Care Management on Clinical Outcomes in Atrial Fibrillation Patients: A Report From the FANTASIIA Registry.
    Esteve-Pastor MA; Ruiz-Ortiz M; Muñiz J; Roldán-Rabadán I; Otero D; Cequier Á; Bertomeu-Martínez V; Badimón L; Anguita M; Lip GYH; Marín F
    Front Cardiovasc Med; 2022; 9():856222. PubMed ID: 35586656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Washam JB; Stevens SR; Lokhnygina Y; Halperin JL; Breithardt G; Singer DE; Mahaffey KW; Hankey GJ; Berkowitz SD; Nessel CC; Fox KA; Califf RM; Piccini JP; Patel MR;
    Lancet; 2015 Jun; 385(9985):2363-70. PubMed ID: 25749644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial.
    Brambatti M; Darius H; Oldgren J; Clemens A; Noack HH; Brueckmann M; Yusuf S; Wallentin L; Ezekowitz MD; Connolly SJ; Healey JS
    Int J Cardiol; 2015 Oct; 196():127-31. PubMed ID: 26093161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation.
    Gallego P; Roldan V; Marín F; Romera M; Valdés M; Vicente V; Lip GY
    Thromb Haemost; 2013 Dec; 110(6):1189-98. PubMed ID: 24096615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the impact of warfarin time in therapeutic range on outcomes of patients with atrial fibrillation in Turkey: perspectives from the observational, prospective WATER Registry.
    Turk UO; Tuncer E; Alioglu E; Yuksel K; Pekel N; Ozpelit E; Vuran O; Tengiz I
    Cardiol J; 2015; 22(5):567-75. PubMed ID: 26100825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry.
    Boriani G; Laroche C; Diemberger I; Fantecchi E; Popescu MI; Rasmussen LH; Dan GA; Kalarus Z; Tavazzi L; Maggioni AP; Lip GY
    Europace; 2016 May; 18(5):648-57. PubMed ID: 26826133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial).
    Bansilal S; Bloomgarden Z; Halperin JL; Hellkamp AS; Lokhnygina Y; Patel MR; Becker RC; Breithardt G; Hacke W; Hankey GJ; Nessel CC; Singer DE; Berkowitz SD; Piccini JP; Mahaffey KW; Fox KA;
    Am Heart J; 2015 Oct; 170(4):675-682.e8. PubMed ID: 26386791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.